TTNP Titan Pharmaceuticals Inc

-0.0018 (-0.38%)
Last Updated: 15:24:50
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 2,113
Bid Price 0.4561
Ask Price 0.4741
News -
Day High 0.4973


52 Week Range


Day Low 0.4525
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0018 -0.38% 0.4719 15:24:50
Open Price Low Price High Price Close Price Prev Close
0.492 0.4525 0.4973 0.4737
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
84 2,113 $ 0.4678862 $ 989 - 0.428 - 1.24
Last Trade Time Type Quantity Stock Price Currency
15:46:55 16 $ 0.4561 USD

Titan Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.09M 15.02M - 557k -10.21M -0.68 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Titan Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No TTNP Message Board. Create One! See More Posts on TTNP Message Board See More Message Board Posts

Historical TTNP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.49740.500.450.470006319,364-0.0255-5.13%
1 Month0.520.5240.450.480679621,635-0.0481-9.25%
3 Months0.610.69840.4280.573443593,140-0.1381-22.64%
6 Months0.740.84510.4280.601017952,657-0.2681-36.23%
1 Year1.091.240.4280.721941741,656-0.6181-56.71%
3 Years5.168.850.34964.623,393,533-4.69-90.85%
5 Years37.80113.400.349613.744,718,872-37.33-98.75%

Titan Pharmaceuticals Description

Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine.
Your Recent History
Titan Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now